These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 1548642

  • 1. Pharmacokinetics of oral 17 beta-estradiol.
    Lobo RA, Cassidenti DL.
    J Reprod Med; 1992 Jan; 37(1):77-84. PubMed ID: 1548642
    [Abstract] [Full Text] [Related]

  • 2. Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.
    Price TM, Blauer KL, Hansen M, Stanczyk F, Lobo R, Bates GW.
    Obstet Gynecol; 1997 Mar; 89(3):340-5. PubMed ID: 9052581
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol.
    Kuhnz W, Gansau C, Mahler M.
    Arzneimittelforschung; 1993 Sep; 43(9):966-73. PubMed ID: 8240460
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of percutaneous estradiol: a crossover study using a gel and a transdermal system in comparison with oral micronized estradiol.
    Scott RT, Ross B, Anderson C, Archer DF.
    Obstet Gynecol; 1991 May; 77(5):758-64. PubMed ID: 2014092
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I, Rovati LC, Vens-Cappell B, Hilgenstock C.
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [Abstract] [Full Text] [Related]

  • 7. Rapid absorption of micronized estradiol-17 beta following sublingual administration.
    Casper RF, Yen SS.
    Obstet Gynecol; 1981 Jan; 57(1):62-4. PubMed ID: 7454177
    [Abstract] [Full Text] [Related]

  • 8. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P, Ozel B, Stanczyk FZ, Felix JC, Mishell DR.
    Menopause; 2008 Jan; 15(1):94-7. PubMed ID: 17882008
    [Abstract] [Full Text] [Related]

  • 9. [Transdermal and oral hormone substitution with estrogens: a comparison].
    Schindler AE.
    Zentralbl Gynakol; 1995 Jan; 117(10):504-7. PubMed ID: 7491831
    [Abstract] [Full Text] [Related]

  • 10. Comparison of estrogen and androgen levels after oral estrogen replacement therapy.
    Slater CC, Zhang C, Hodis HN, Mack WJ, Boostanfar R, Shoupe D, Paulson RJ, Stanczyk FZ.
    J Reprod Med; 2001 Dec; 46(12):1052-6. PubMed ID: 11789085
    [Abstract] [Full Text] [Related]

  • 11. Short-term effects of smoking on the pharmacokinetic profiles of micronized estradiol in postmenopausal women.
    Cassidenti DL, Vijod AG, Vijod MA, Stanczyk FZ, Lobo RA.
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1953-60. PubMed ID: 2256508
    [Abstract] [Full Text] [Related]

  • 12. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
    Ritter CL, Prigge WF, Reichert MA, Malejka-Giganti D.
    Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
    [Abstract] [Full Text] [Related]

  • 13. Puberty induction in Turner syndrome: results of oestrogen treatment on development of secondary sexual characteristics, uterine dimensions and serum hormone levels.
    Bannink EM, van Sassen C, van Buuren S, de Jong FH, Lequin M, Mulder PG, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):265-73. PubMed ID: 19200215
    [Abstract] [Full Text] [Related]

  • 14. Biological effects of estradiol-17 beta in postmenopausal women: oral versus percutaneous administration.
    De Lignieres B, Basdevant A, Thomas G, Thalabard JC, Mercier-Bodard C, Conard J, Guyene TT, Mairon N, Corvol P, Guy-Grand B.
    J Clin Endocrinol Metab; 1986 Mar; 62(3):536-41. PubMed ID: 3080464
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of a new conjugated oral estrogen, estradiol-3beta-glucoside, with oral micronized 17beta-estradiol in postmenopausal women.
    Sweeney AT, Tangpricha V, Weinberg J, Malabanan AO, Chimeh FN, Holick MF.
    Transl Res; 2006 Oct; 148(4):164-70. PubMed ID: 17002918
    [Abstract] [Full Text] [Related]

  • 16. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Oct; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 17. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE, Bolt HM, Zwirner M, Hochlehnert G, Göser R.
    Arzneimittelforschung; 1982 Oct; 32(7):787-91. PubMed ID: 6289846
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest.
    Zeun S, Lu M, Uddin A, Zeiler B, Morrison D, Blode H.
    Eur J Contracept Reprod Health Care; 2009 Jun; 14(3):221-32. PubMed ID: 19565420
    [Abstract] [Full Text] [Related]

  • 19. Pharmacokinetics and testosterone suppression of a single dose of polyestradiol phosphate (Estradurin) in prostatic cancer patients.
    Stege R, Gunnarsson PO, Johansson CJ, Olsson P, Pousette A, Carlström K.
    Prostate; 1996 May; 28(5):307-10. PubMed ID: 8610057
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of orally administered estradiol valerate. Results of a single-dose cross-over bioequivalence study in postmenopausal women.
    Zimmermann H, Koytchev R, Mayer O, Börner A, Mellinger U, Breitbarth H.
    Arzneimittelforschung; 1998 Sep; 48(9):941-7. PubMed ID: 9793623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.